Tech Company Financing Transactions
4D Molecular Therapeutics Funding Round
Viking Global Investors, ArrowMark Partners and Berkeley Catalyst Fund participated in a $90 million Series B funding round for 4D Molecular Therapeutics. The round was announced by the company on 9/6/2018.
Transaction Overview
Company Information
Emeryville, CA 94608
USA
Management Team
Browse more venture capital transactions:
Prev: 9/6/2018: Sarcos Robotics venture capital transaction
Next: 9/6/2018: Carillon Technologies venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on funding rounds that are announced publicly. All VC database entries reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs